XML 33 R22.htm IDEA: XBRL DOCUMENT v3.23.3
Segment Reporting
9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Segment Reporting

Note 14 – Segment Reporting

Segment information is used by management for making operating decisions for the Company. Management evaluates the performance of the Company’s segments based primarily on operating income or loss.

The Company’s reportable segments are as follows:

Automotive – this segment represents the design, development, manufacturing and sales of automotive climate comfort systems, automotive cable systems, lumbar and massage comfort solutions, valve systems, battery performance solutions, and automotive electronic and software systems.
Medical – this segment represents the results from our patient temperature management business within the medical industry.

The Corporate category includes unallocated costs related to our corporate headquarter activities, including selling, general and administrative costs and acquisition transaction costs, which do not meet the requirements for being classified as an operating segment.

The tables below present segment information about the reported Product revenues, Depreciation and amortization and Operating income (loss) of the Company for the three and nine months ended September 30, 2023 and 2022.

Three Months Ended September 30,

 

Automotive

 

 

Medical

 

 

Corporate

 

 

Total

 

2023

 

 

 

 

 

 

 

 

 

 

 

 

Product revenues

 

$

354,782

 

 

$

11,413

 

 

$

 

 

$

366,195

 

Depreciation and amortization

 

 

11,399

 

 

 

882

 

 

 

173

 

 

$

12,454

 

Operating income (loss)

 

 

41,690

 

 

 

(805

)

 

 

(17,144

)

 

$

23,741

 

2022

 

 

 

 

 

 

 

 

 

 

 

 

Product revenues

 

$

322,555

 

 

$

10,407

 

 

$

 

 

$

332,962

 

Depreciation and amortization

 

 

10,499

 

 

 

1,035

 

 

 

302

 

 

$

11,836

 

Operating income (loss)

 

 

43,067

 

 

 

(2,232

)

 

 

(18,014

)

 

$

22,821

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended September 30,

 

Automotive

 

 

Medical

 

 

Corporate

 

 

Total

 

2023

 

 

 

 

 

 

 

 

 

 

 

 

Product revenues

 

$

1,069,007

 

 

$

33,136

 

 

$

 

 

$

1,102,143

 

Depreciation and amortization

 

 

34,910

 

 

 

2,756

 

 

 

865

 

 

$

38,531

 

Operating income (loss)

 

 

126,630

 

 

 

(21,838

)

 

 

(59,056

)

 

$

45,736

 

2022

 

 

 

 

 

 

 

 

 

 

 

 

Product revenues

 

$

829,570

 

 

$

31,764

 

 

$

 

 

$

861,334

 

Depreciation and amortization

 

 

27,333

 

 

 

2,224

 

 

 

913

 

 

$

30,470

 

Operating income (loss)

 

 

98,367

 

 

 

(3,264

)

 

 

(50,356

)

 

$

44,747

 

Automotive and Medical segment Product revenues by product category for the three and nine months ended September 30, 2023 and 2022 were as follows:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Climate Control Seat

 

$

124,905

 

 

$

112,059

 

 

$

360,868

 

 

$

311,281

 

Seat Heaters

 

 

77,238

 

 

 

75,568

 

 

 

231,132

 

 

 

210,367

 

Steering Wheel Heaters

 

 

39,861

 

 

 

31,482

 

 

 

115,166

 

 

 

89,169

 

Lumbar and Massage Comfort Solutions (a)

 

 

33,260

 

 

 

22,740

 

 

 

109,602

 

 

 

22,740

 

Valve Systems (a)

 

 

27,830

 

 

 

18,542

 

 

 

82,516

 

 

 

18,542

 

Automotive Cables

 

 

19,668

 

 

 

18,338

 

 

 

60,131

 

 

 

59,662

 

Battery Performance Solutions

 

 

17,242

 

 

 

20,331

 

 

 

57,138

 

 

 

55,395

 

Electronics

 

 

10,163

 

 

 

12,083

 

 

 

30,456

 

 

 

33,190

 

Other Automotive

 

 

4,615

 

 

 

11,412

 

 

 

21,998

 

 

 

29,224

 

Subtotal Automotive segment

 

 

354,782

 

 

 

322,555

 

 

 

1,069,007

 

 

 

829,570

 

Medical segment (b)

 

 

11,413

 

 

 

10,407

 

 

 

33,136

 

 

 

31,764

 

Total Company

 

$

366,195

 

 

$

332,962

 

 

$

1,102,143

 

 

$

861,334

 

(a)
Represents Product revenues from Alfmeier (acquired on August 1, 2022) - (see Note 2)
(b)
Includes Product revenues of $1,988 and $4,939 for the three and nine months ended September 30, 2023, respectively, and $1,234 for the three and nine months ended September 30, 2022 from Dacheng (acquired on July 13, 2022) - (see Note 2)

Total Product revenues information by geographic area for the three and nine months ended September 30, 2023 and 2022 is as follows (based on shipment destination):

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

United States

 

$

134,588

 

 

$

131,021

 

 

$

414,359

 

 

$

337,759

 

China

 

 

61,004

 

 

 

57,439

 

 

 

161,530

 

 

 

127,183

 

South Korea

 

 

27,369

 

 

 

22,751

 

 

 

86,102

 

 

 

67,632

 

Germany

 

 

24,456

 

 

 

19,454

 

 

 

77,007

 

 

 

54,805

 

Czech Republic

 

 

16,684

 

 

 

13,247

 

 

 

51,706

 

 

 

35,630

 

Japan

 

 

16,906

 

 

 

17,603

 

 

 

44,995

 

 

 

42,305

 

Romania

 

 

13,828

 

 

 

11,592

 

 

 

39,797

 

 

 

35,866

 

Slovakia

 

 

10,946

 

 

 

8,109

 

 

 

35,254

 

 

 

25,755

 

Mexico

 

 

15,251

 

 

 

7,062

 

 

 

34,701

 

 

 

16,171

 

Finland

 

 

8,286

 

 

 

9,757

 

 

 

29,558

 

 

 

26,244

 

Other

 

 

36,877

 

 

 

34,927

 

 

 

127,134

 

 

 

91,984

 

Total Non-U.S.

 

 

231,607

 

 

 

201,941

 

 

 

687,784

 

 

 

523,575

 

Total Company

 

$

366,195

 

 

$

332,962

 

 

$

1,102,143

 

 

$

861,334